Sept 4 (Reuters) - Sprout Pharmaceuticals:
* FDA REMOVES ALCOHOL BAN WITH ADDYI - THE FIRST-AND-ONLY NON-HORMONAL TREATMENT FOR HYPOACTIVE (LOW) SEXUAL DESIRE DISORDER (HSDD)
* SPROUT - FDA ALSO REMOVED REQUIREMENT UNDER ITS REMS PROGRAM FOR HEALTHCARE PRACTITIONERS OR PHARMACIES TO BE CERTIFIED TO PRESCRIBE OR DISPENSE ADDYI
* SPROUT - TO MAKE ALL LABELING ELEMENTS CONSISTENT WITH FDA'S FINDINGS, BOXED WARNING WILL CHANGE
* SPROUT - FDA STATED THAT PATIENTS SHOULD DISCONTINUE DRINKING ALCOHOL AT LEAST TWO HOURS BEFORE TAKING ADDYI